Most methicillin-resistant Staphylococcus aureus (MRSA) strains produce ,B-lactamase. To determine whether this enzyme(s) is identical to one or more of the four P-lactamases produced by methicillin-susceptible strains, the P-lactamases of 50 MRSA isolates were typed by using substrate profile analysis. Forty type A, no type B, ten type C, and no type D P-lactamase-producing strains Forty type A and ten type C 3-lactamase-producing MRSA isolates were identified. No MRSA isolate produced either the type B or the type D 3-lactamase. Type A 3-lactamaseproducing MRSA strains were identified from each of the nine locations, whereas type C enzyme-producing strains were found in only three sites-seven from New Orleans, two from Charleston, and one from Salt Lake City.
cefazolin, for type A and type C MRSA strains.
Although it is well established that the major mechanism of resistance to methicillin and other antistaphylococcal penicillins in Staphylococcus aureus involves the production of an additional membrane penicillin-binding protein, PBP 2a, most methicillin-resistant S. aureus (MRSA) strains also produce 1-lactamase (1, 6) . There is, however, only limited information about the relationship between the ,-lactamase(s) of MRSA strains and the four ,B-lactamases (types A, B, C, and D) produced by methicillin-susceptible strains of S. aureus. In 1969, Dyke reported that all of 27 unique isolates of MRSA produced serotype A 3-lactamase (1) . The depletion of Richmond's typing antiserum in the early 1970s (14) and the absence of alternative methods for differentiating between variants of staphylococcal 3-lactamase until recently (7, 8) have prevented additional investigations regarding specific 3- aureus strains (7, 8, 10, 13, 14) . In contrast, the type B P-lactamase is fairly common among methicillin-susceptible strains (7, 8, 13) . Production of the type B 3-lactamase historically has been restricted to isolates typeable by group II bacteriophages (13), however, and this phage group is infrequently associated with methicillin resistance (5, 12, 15) . The presence of both type A and type C enzymes among strains from three of the institutions we surveyed suggests the existence of at least two subpopulations of MRSA at these sites. When quantitative differences in 1-lactamase production are considered, even greater heterogeneity among the strains is observed (data not shown). Since most MRSA strains belong to phage group III or are nontypeable (5, 12, 15) , phage typing often has limited utility in determining the degree of identity or distinctness of epidemiologically related isolates. In some circumstances, ,B-lactamase typing and quantitation assays may be useful in discriminating between different MRSA isolates, although the epidemiologic value of such assays remains to be compared with other methods of strain identification. Since the gene encoding 13-lactamase is usually located on a plasmid and because S. aureus strains can lose or gain plasmids over time, this observation should not be interpreted as evidence for or against a clonal origin of MRSA.
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